Anti-Human IL6R Recombinant Antibody(Satralizumab)

Product Information

Catalog Number	YR1396
Product Name	Anti-Human IL6R Recombinant Antibody(Satralizumab)
Molecular Name	Satralizumab
Alias	Anti-IL6R Recombinant Antibody, Research Grade Satralizumab
CAS Number	1535963-91-7
Target	IL6R[Homo sapiens]
Isotype	IgG2 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price